Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 6:27 PM
Ignite Modification Date: 2025-12-25 @ 3:57 PM
NCT ID: NCT03124368
Description: \[Not specified\]
Frequency Threshold: 0
Time Frame: After the first dose of study medication (following Day 0) through the follow-up visit at Day 49.
Study: NCT03124368
Study Brief: A Proof-of-Mechanism Study to Determine the Effect of Danicopan on C3 Levels in Participants With C3G or IC-MPGN
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Group 1: Danicopan 100 mg TID (Sentinel) Participants received 100 mg of danicopan TID during the Treatment Period. 0 None 0 2 2 2 View
Group 2: Danicopan up to 200 mg TID Participants received not more than 200 mg of danicopan TID during the Treatment Period. 0 None 1 4 3 4 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Presyncope SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (20.0) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (20.0) View
Upper respiratory tract infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (20.0) View
Hypokalaemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA (20.0) View
Diarrhoea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (20.0) View
Hypotension SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA (20.0) View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (20.0) View
Pain SYSTEMATIC_ASSESSMENT General disorders MedDRA (20.0) View
Crepitations SYSTEMATIC_ASSESSMENT General disorders MedDRA (20.0) View
Prerenal failure SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA (20.0) View
Hyperkalaemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA (20.0) View
Anaemia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders MedDRA (20.0) View